New Treatments for Women's Sexual and Genital Health

Stephanie S. Faubion, Jordan Rullo

Research output: Contribution to journalArticlepeer-review


Flibanserin is a new FDA approved treatment for low sexual desire in premenopausal women. DHEA, lidocaine, and lasers are experimental and potentially promising treatments that are available for management of vaginal dryness and dyspareunia in women. Additional long-term, randomized controlled trial data regarding long-term safety and efficacy will be welcomed for these experimental therapies.

Original languageEnglish (US)
Pages (from-to)514-516
Number of pages3
JournalJournal of Women's Health
Issue number5
StatePublished - May 1 2016

ASJC Scopus subject areas

  • General Medicine


Dive into the research topics of 'New Treatments for Women's Sexual and Genital Health'. Together they form a unique fingerprint.

Cite this